The Nordic region (Sweden, Denmark, Norway, Finland, Iceland) is highly regarded as one of the most advanced places to develop and access high quality data. These countries boast arguably the world’s most advanced healthcare systems, with strong levels of access to the latest medicines, so they continue to be an attractive place to run clinical trials as well as prospective real world studies. However, because every patient has a unique patient number from birth to death, these countries are unique in terms of tracking patient-level data. The Nordic healthcare systems offer a unique opportunity for life science researchers to access these high-quality, granular-level, validated, external data sources. Retrospective or pragmatic studies in the Nordic region, if performed correctly, are a unique and unequaled opportunity to generate high-quality evidence that can help pharma and medtech companies understand and demonstrate the value of their medicines to physicians, payers and patients in the region and beyond.

5 Reasons to attend -You will learn:

1. Learn how to take advantage of the Nordic region for clinical, real-world and pragmatic studies, especially through accessing unique external data sources.
2. Market Access, HEOR, Reimbursement professionals: Understand reimbursement pathways and the evidence requirements of payers and HTAs.
3. Medical Affairs Professionals: Appreciate how to leverage the power of medical affairs to develop evidence and communicate it’s value to stakeholders.
4. Medical Device industry executives: Obtain the latest information on how to navigate complex reimbursement pathways for advanced devices and diagnostics
5. Network with the regions thought leaders, stakeholders and experts, especially at the exclusive networking dinner. Have your questions answered through interactive panel discussions.

Request agenda here for complete speaker list

PAYERS, HTAS & POLICY MAKERS

Head of Healthcare Development Department
Stockholm County Council

Associate Director of Medicines Optimisation, DGS & Swale CCGs
NHS

CEO
Healthcare DENMARK

Associate Professor in Medical Ethics Centre for Research Ethics & Bioethics
Uppsala University

Business Development Officer
NIHR Clinical Research Network
 

PATIENTS

Founder & CEO, Patient In Focus
Chairwoman, EUPATI

Patient Representative & Inclusion Advocate Chair: Access Matters, Midstream,
Board Member; European Forum for Good Clinical Practice (EFGCP), Healthcare Quality Improvement Partnership (HQIP), International Foundation for Integrated Care (IFIC)

PHARMA INDUSTRY

Senior Director, Real World Evidence
Janssen

Director, Feasibility Lead
Pfizer

Nordic Head of RWE and Epidemiology,
Janssen

Market Access Lead
Bristol-Myers Squibb

Value & HTA Lead, Nordics
Bristol-Myers Squibb

Global Patient Outcomes and Real-World Evidence International Scientist, Nordic
Eli Lilly

Vice President, Europe Area Medical Director
GSK

Medical Director, Nordic & Benelux,
Otsuka

Medical Director Nordic/Baltic,
Kyowa Kirin

Nordic Medical Affairs Director,
Janssen

Senior Adviser, Manager of Research and Development
The Association for Pharma Industry, Legemiddelindustrien (LMI)

Nordic Therapeutic Area Head Lymphoma
Janssen

Sr. Medical Project Manager, RWE Lead, Medical Affairs
Novo Nordisk

Head Medical Affairs Nordic
Sandoz
 

MEDTECH INDUSTRY

Global Market Access Manager, EMEA lead
EMEA, Abbott

Product Specialist Surgical
Stryker
 

EXPERT SOLUTION PROVIDER

Project Manager & RWE Expert
Institute of Applied Economics & Health Research (ApHER)

CEO
Synergus RWE

Senior Advisor
IHE - Swedish Institute for Health Economics

Request agenda here for complete speaker list

Pictures from recent Nordic Leaders Forum. Imagine being there...

SPEAKER LIST - DAY 1

Senior Director, Real World Evidence
Janssen

Director, Feasibility Lead
Pfizer

Business Development Officer
NIHR Clinical Research Network

Nordic Head of RWE and Epidemiology,
Janssen

Global Market Access Manager, EMEA lead
EMEA, Abbott

CEO
Healthcare DENMARK

Sr. Medical Project Manager, RWE Lead, Medical Affairs
Novo Nordisk

Associate Professor in Medical Ethics Centre for Research Ethics & Bioethics
Uppsala University

Founder and CEO, Lupus Friends and Family Foundation
Chairwoman, EUPATI

Patient Representative & Inclusion Advocate Chair: Access Matters, Midstream,
Board Member; European Forum for Good Clinical Practice (EFGCP), Healthcare Quality Improvement Partnership (HQIP), International Foundation for Integrated Care (IFIC)

 

This stream will discuss the payer and HTA agencies’ challenges in budget management and cost-containment, compared to their enthusiasm to reimburse expensive treatments and diagnostics. Participants will learn how drugs and technologies of high clinical and economic benefit will be assessed by payers, and how they can further develop, measure, demonstrate and deliver this value to health systems.

SPEAKER LIST - DAY 2 - STREAM 1

Head of Healthcare Development Department
Stockholm County Council

Market Access Lead
Bristol-Myers Squibb

Value & HTA Lead, Nordics
Bristol-Myers Squibb

Managing Director & CEO
IHE - Swedish Institute for Health Economics

Project Manager
ApHER

Global Patient Outcomes and Real-World Evidence International Scientist, Nordic
Eli Lilly

Associate Director of Medicines Optimisation, DGS & Swale CCGs
NHS

  1. Understand how medical affairs are at the forefront of new pharmaceutical industry commercial models and what needs to be done to maximise success.

  2. Discover which are the most intelligent ways to map, communicate with and engage with Nordic KOLs and other prescribers, payers, patient groups, pharmacies and tomorrow’s stakeholders.

  3. Measure the performance of your medical affairs and MSL teams and individuals to improve effectiveness.

  4. Benchmark with experts to find out the best practices in late phase research, especially observational studies, patient registries and investigator-initiated studies in the Nordic region.

SPEAKER LIST - DAY 2 - STREAM 2

Vice President, Europe Area Medical Director
GSK

Medical Director, Nordic & Benelux,
Otsuka

Medical Director Nordic/Baltic,
Kyowa Kirin

Head Medical Affairs Nordic
Sandoz

Nordic Medical Affairs Director,
Janssen

Nordic Therapeutic Area Head Lymphoma
Janssen

Product Specialist Surgical
Stryker

 

Event Partners

Media Partners

This event is accredited for CPD (Continuing Professional Development) status

Share with Colleagues